돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 269828생성일: 2026년 10월 26일

Sodium Hydroxide → 1-Methyl-4-[3-(4-nitrophenyl)-4-oxo-4-piperidin-1-ylbutanoyl]piperazine

https://huagongshe.com/reaction/269828

반응식

참여 물질

역할이름HCID투입량
반응물Sodium HydroxideHCID 14798—
반응물1-MethylpiperazineHCID 53167—
반응물Methyl bromoacetateHCID 60984—
반응물1-[(4-Nitrophenyl)acetyl]piperidineHCID 3594276—
용매MethanolHCID 887—
생성물1-Methyl-4-[3-(4-nitrophenyl)-4-oxo-4-piperidin-1-ylbutanoyl]piperazineHCID 67388518—

반응 단계

1-[(4-Nitrophenyl)acetyl]piperidine was alkylated with methyl -bromoacetate in the same manner as in Reference Example 47, hydrolyzed with 1 M sodium hydroxide aqueous solution in methanol, and then condensed with 1-methylpiperazine in the same manner as in Reference Example 5 to obtain 1-methyl-4-[3-(4-nitrophenyl)-4-oxo-4-piperidin-1-ylbutanoyl]piperazine (ESI: 389). This piperazine compound was subjected to the reduction of nitro group in the same manner as the catalytic hydrogenation shown in Reference Example 3 and then treated with lithium aluminum hydride to obtain 4-[3-(4-methylpiperazin-1-yl)-1-(piperidin-1-ylmethyl)propyl]aniline. ESI: 331.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07449456B2
출처 데이터셋uspto-grants-2008_11
ORD IDord-aa9c27791de64b749e28758bedf6fb33
출처 메모uspto-grants-2008_11